Author Archives: azaleaazelia

About azaleaazelia

A nice person... :)

COVID-19 vaccine development part 26

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 25

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 24

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 23

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 22

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 21

Resources on COVID-19 vaccines development: WHO target product profile for COVID-19 vaccine Vaccine landscape Solidarity vaccine trial Access to COVID tools (ACT) Accelerator COVAX facility (WHO) Covax explained (GAVI) COPVAX (CEPI) WHO guidance on ethnics of vaccine allocation

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 20

Working together to deliver vaccine to all countries: The Access to Covid-19 Tools (ACT) Accelerator was launched in April 2020 to speed up development and delivery to countries of diagnostics, treatments and vaccines. It includes a health systems connector to … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 19

WHO Solidarity vaccine trial (Achieving rapid progress towards global objectives) : Evaluating several different candidate vaccines:       Increasing the likelihood of finding several effective vaccines Expenditiously enrolling people at sites with high rates of COVID-19:       … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 18

WHO COVID-19 Solidarity vaccine trial : On 28 May 2020, WHO announced the launch of a coordinated international, concurrent randomized controlled Phase III trial of different vaccine candidates A trial in several sites at once will help speed evaluation and … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 17

COVID-19 vaccine candidates in Phase III trials : As of 02 October 2020 there are 42 COVID-19 candidate vaccines in clinical evaluation of which 10 in phase III trials There are another 151 candidate vaccines in preclinical evaluation Phase III … Continue reading

Posted in Tak Berkategori | Leave a comment